Outlook Therapeutics, Inc

(NASDAQ:OTLK)

Latest On Outlook Therapeutics, Inc (OTLK):

Date/Time Type Description Signal Details
2023-05-15 13:32 ESTNewsOutlook Therapeutics GAAP EPS of -$0.03N/A
2023-04-28 22:38 ESTNewsOutlook Therapeutics: August PDUFA For Wet AMD BlockbusterN/A
2023-02-06 21:05 ESTNewsOutlook draws bullish views at Cantor on potential FDA nod for lead assetN/A
2022-12-29 21:46 ESTNewsOutlook Therapeutics GAAP EPS of -$0.31 in-lineN/A
2022-12-23 12:09 ESTNewsOutlook Therapeutics up 3% on $25M direct offeringN/A
2022-12-23 12:09 ESTNewsOutlook enters definitive agreement for $31.8M convertible promissory noteN/A
2022-10-28 19:52 ESTNewsFDA accepts Outlook Therapeutics' biologics license application for wet AMD drugN/A
2022-09-27 15:20 ESTNewsOutlook Therapeutics ties up with AmerisourceBergen for anticipated launch of wet AMD drugN/A
2022-08-31 01:01 ESTNewsOutlook Therapeutics resubmits application for eye disease wAMD drug, shares rise 8%N/A
2022-08-10 21:45 ESTNewsOutlook Therapeutics GAAP EPS of -$0.08 misses by $0.01N/A
2022-06-14 20:49 ESTNewsOutlook to re-submit application for eye disorder drug in Sept. after FDA correspondenceN/A
2022-06-09 23:27 ESTNewsOutlook Therapeutics: A One-Buck Lottery TicketN/A
2022-05-31 09:19 ESTNewsOutlook stock slumps 38% as it pulls filing for eye disorder drug after FDA seeks more infoN/A
2022-05-14 01:06 ESTNewsOutlook Therapeutics GAAP EPS of -$0.09 misses by $0.03N/A
2022-05-12 22:48 ESTNewsOutlook Therapeutics Q1 2022 Earnings PreviewN/A
2022-03-31 15:19 ESTNewsOutlook Therapeutics files for FDA approval of ONS-5010 for eye disorderN/A
2022-02-14 12:28 ESTNewsOutlook Therapeutics GAAP EPS of -$0.08N/A
2022-01-25 17:04 ESTNewsOutlook Therapeutics provides business updates for 2022N/A
2022-01-21 15:01 ESTNewsOutlook Therapeutics: Likely FDA Approval, Possible BuyoutN/A
2021-12-08 11:11 ESTNewsOutlook Therapeutics tracks higher as CEO, COO buy sharesN/A
2021-11-24 03:30 ESTNewsOutlook Therapeutics under pressure on plans to raise $10M in stock offeringN/A
2021-11-24 03:30 ESTNewsOutlook Therapeutics secures $50M capital through stock offeringN/A
2021-11-15 10:15 ESTNewsOutlook Therapeutics to file marketing application for wet AMD therapy in Q1 2022N/A
2021-10-12 11:02 ESTNewsWarning: OTLK is at high risk of performing badlyN/A
2021-10-06 14:27 ESTNewsOTLK is at high risk of performing badlyN/A
2021-09-30 20:19 ESTNewsWarning: OTLK has been downgraded to Very BearishN/A
2021-09-28 22:11 ESTNewsOutlook Therapeutics reports 12-month safety data from late-stage bevacizumab-vikg study in wet AMDN/A
2021-08-24 08:18 ESTNewsOutlook Therapeutics (OTLK) Investor Presentation - SlideshowN/A
2021-08-13 18:46 ESTNewsOutlook Therapeutics EPS in-lineN/A
2021-08-03 16:27 ESTNewsOutlook Therapeutics shares surge on late-stage wet AMD bevacizumab study resultsN/A
2021-07-21 19:05 ESTNewsOutlook Therapeutics completes patient dosing in wet AMD trialN/A
2021-07-21 18:45 ESTNewsOutlook Therapeutics names Russell Trenary as president and chief executive officerN/A
2021-04-01 02:05 ESTNewsOutlook Therapeutics reports positive results from NORSE THREE study in retinal diseaseN/A
2021-03-09 21:35 ESTNewsThe Outlook For Outlook TherapeuticsN/A
2021-02-19 00:23 ESTAnalyst RatingThe Analyst Target Price has increased from $4.88 to $5.25.Buy
2021-02-17 16:05 ESTFinancialsCompany financials have been released.Neutral
2021-02-17 12:00 ESTEarnings EstimateAn EPS average of -$0.08 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-16 14:00 ESTNewsOutlook Therapeutics EPS misses by $0.03N/A
2021-02-10 16:31 ESTNewsOutlook Therapeutics jumps 52% after a surge in insider purchasesN/A
2021-02-10 08:12 ESTAnalyst RatingThe Analyst Target Price has increased from $4.63 to $4.88.Buy
2021-02-04 19:16 ESTNewsOutlook gives update on ONS-5010 BLA progress after recent fundingN/A
2021-01-29 05:00 ESTNewsOutlook Therapeutics raises $10M capitalN/A
2021-01-29 05:00 ESTNewsOutlook Therapeutics to raise $35M in stock offeringN/A
2021-01-08 08:19 ESTAnalyst RatingThe Analyst Target Price has increased from $4.56 to $4.63.Buy
2021-01-01 08:29 ESTAnalyst RatingThe Analyst Target Price has decreased from $5.25 to $4.56.Neutral
2020-12-24 16:31 ESTFinancialsCompany financials have been released.Neutral
2020-12-24 16:31 ESTEarnings EstimateAn EPS average of -$0.08 is estimated for the quarter ending on March 31, 2021.Buy
2020-12-24 16:31 ESTEarnings EstimateAn EPS average of -$0.20 is estimated for the 2022 year.Sell
2020-12-23 17:28 ESTNewsOutlook Therapeutics EPS beats by $0.01N/A
2020-12-23 17:28 ESTNewsOutlook Therapeutics reports FY20 results: updates clinical programN/A

About Outlook Therapeutics, Inc (OTLK):

Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, a proprietary ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cranbury, New Jersey.

OTLK Quotes by TradingView

See Advanced Chart

General

  • Name Outlook Therapeutics, Inc
  • Symbol OTLK
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 8
  • Last Split Factor1:8
  • Last Split Date2019-03-18
  • Fiscal Year EndSeptember
  • IPO Date2016-05-13
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.outlooktherapeutics.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 13.27
  • Price/Book (Most Recent Quarter) 142.98
  • Enterprise Value Revenue 26.1
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.35
  • Next Year EPS Estimate -$0.19
  • Next Quarter EPS Estimate -$0.08
  • Return on Assets -231%
  • Return on Equity -737%
  • Revenue 5.85 million
  • Earnings Per Share -$2.89
  • Revenue Per Share $0.12
  • Gross Profit -26341998
  • Quarterly Earnings Growth 658.3%
View More

Highlights

  • Market Capitalization 414.5 million
  • EBITDA -29723352
  • PE Ratio -3.53
  • Analyst Target Price $5.25
  • Book Value Per Share $0.02
View More

Share Statistics

  • Shares Outstanding 173.43 million
  • Shares Float 88.48 million
  • % Held by Insiders 5719%
  • % Held by Institutions 3.09%
  • Shares Short 289414
  • Shares Short Prior Month 884117
  • Short Ratio 0.03
View More

Technicals

  • Beta 0.69
  • 52 Week High $4.26
  • 52 Week Low $0.5
  • 50 Day Moving Average 2.11
  • 200 Day Moving Average 1.28
View More

Dividends

  • Dividend Date 2019-03-18
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Outlook Therapeutics, Inc (OTLK) Dividend Calendar:

OTLK's last dividend payment was made to shareholders on March 18, 2019.

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Outlook Therapeutics, Inc (OTLK) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-16$N/A-$0.11-$0.08-33.33%
2020-09-302020-12-23$N/A-$0.03-$0.0972.66%
2020-06-302020-08-14$N/A-$0.11-$0.10-15.79%
2020-03-312020-05-15$N/A-$0.13-$0.12-6.12%
2019-12-312020-02-14$N/A-$0.28-$0.22-27.27%
2019-09-302019-12-19$5.85 million$0.05-$0.31117.28%
2019-06-302019-08-14$583848-$0.24-$0.3633.94%
2019-03-312019-05-15$641140-$0.96-$0.66-45.91%
2018-12-312019-02-14$1.07 million-$0.72
2018-09-302018-12-18$771890-$1.40
2018-06-302018-08-14$771890-$1.60-$1.8413.04%
2018-03-312018-05-15$771890-$2.56-$1.84-39.13%
2017-12-312018-02-14$772000-$1.60-$1.9216.67%
2017-09-302017-12-29$2.9 million-$1.79-$4.9663.95%
2017-06-302017-08-14$303000-$2.97-$5.1241.97%
2017-03-312017-05-15$303000-$3.06-$7.6059.71%
2016-12-312017-02-14$303000-$6.56-$7.6814.58%
2016-09-302016-12-29$495000-$1.92-$6.0068%
2016-06-302016-08-15$495000-$12.80-$6.00-113.33%
2016-03-312016-06-27$995000-$2.56-$6.0057.33%

Outlook Therapeutics, Inc (OTLK) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Outlook Therapeutics, Inc (OTLK) Chart:

Outlook Therapeutics, Inc (OTLK) News:

Below you will find a list of latest news for Outlook Therapeutics, Inc (OTLK) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Outlook Therapeutics, Inc (OTLK) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-05-160.50.95CALL0 11457.43TRUE00
2025-05-1610CALL0 0259.29TRUE00
2025-05-161.50.4CALL0 7470.86TRUE00
2025-05-1620.15CALL0 2828.62FALSE00
2025-05-162.50.05CALL0 877273.58FALSE00
2025-05-1650.05CALL0 222513.09FALSE00
2025-05-167.50.02CALL0 2281115.02FALSE00
2025-05-16100.05CALL0 87927.43FALSE00
2025-05-1612.50.05CALL0 110FALSE00
2025-05-160.50PUT0 00FALSE00
2025-05-1610.08PUT0 28516.78FALSE00
2025-05-161.50PUT0 0279.19FALSE00
2025-05-1620PUT0 0609.42TRUE00
2025-05-162.51.05PUT0 2289.79TRUE00
2025-05-1653.18PUT0 0538.65TRUE00
2025-05-167.50PUT0 0666.71TRUE00
2025-05-16100PUT0 0753.02TRUE00
2025-05-1612.50PUT0 0818.08TRUE00
2025-06-202.50CALL0 0239.18FALSE00
2025-06-2050CALL0 0480.23FALSE00
2025-06-207.50CALL0 0538.5FALSE00
2025-06-202.50PUT0 0308.07TRUE00
2025-06-2050PUT0 0405.56TRUE00
2025-06-207.50PUT0 0467.06TRUE00
2025-08-150.50CALL0 0310.03TRUE00
2025-08-1510.3CALL0 354.05TRUE00
2025-08-151.50.3CALL0 8106.52TRUE00
2025-08-1520.7CALL0 4155.94FALSE00
2025-08-152.50.2CALL0 493170.74FALSE00
2025-08-1550.1CALL0 57311.56FALSE00
2025-08-157.50.5CALL0 1349.51FALSE00
2025-08-150.50PUT0 00FALSE00
2025-08-1510.2PUT0 5281.57FALSE00
2025-08-151.50.43PUT0 0113.49FALSE00
2025-08-1520PUT0 0123.93TRUE00
2025-08-152.51.77PUT0 51235.76TRUE00
2025-08-1550PUT0 0302.19TRUE00
2025-08-157.50PUT0 0345.03TRUE00
2025-11-210.50CALL0 0454.98TRUE00
2025-11-2110.75CALL0 6137.14TRUE00
2025-11-211.50.97CALL0 1097.57TRUE00
2025-11-2120.6CALL0 7114.43FALSE00
2025-11-212.50CALL0 0147.46FALSE00
2025-11-2150CALL0 00FALSE00
2025-11-217.50CALL0 00FALSE00
2025-11-210.50PUT0 0263.99FALSE00
2025-11-2110PUT0 0155.11FALSE00
2025-11-211.50.75PUT0 4106.27FALSE00
2025-11-2120PUT0 0118.46TRUE00
2025-11-212.50PUT0 0124.86TRUE00
2025-11-2150PUT0 0466.31TRUE00
2025-11-217.50PUT0 0324.55TRUE00
2027-01-150.51.34CALL0 8138.7TRUE00
2027-01-1511.45CALL3 0281.84TRUE1.450
2027-01-151.50.8CALL0 200186.76TRUE00
2027-01-1520.9CALL0 1199.43FALSE00
2027-01-152.50.8CALL1 1092131.94FALSE0.80
2027-01-1550.35CALL0 13147.52FALSE00
2027-01-157.50.25CALL0 1149.5FALSE00
2027-01-15100.5CALL0 15165.89FALSE00
2027-01-1512.50.3CALL0 10160.44FALSE00
2027-01-150.50.26PUT0 50FALSE00
2027-01-1510.6PUT0 4234.3FALSE00
2027-01-151.50.62PUT0 200187.92FALSE00
2027-01-1521.3PUT0 8181.21TRUE00
2027-01-152.51.75PUT0 2184.04TRUE00
2027-01-1550PUT0 0180.97TRUE00
2027-01-157.50PUT0 0175.58TRUE00
2027-01-15100PUT0 0164.86TRUE00
2027-01-1512.50PUT0 0163.91TRUE00

Latest OTLK Trades:

Date Shares Price
Jun 13, 2022 7:57 PM EST100$0.915
Jun 13, 2022 7:57 PM EST100$0.9104
Jun 13, 2022 7:58 PM EST100$0.9199
Jun 13, 2022 7:59 PM EST100$0.9168
Jun 13, 2022 7:59 PM EST100$0.9168

Outlook Therapeutics, Inc (OTLK) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120038577/0001209191-20-038577-index.htm
2019-02-27UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1649989/000000000019003313/0000000000-19-003313-index.htm
2020-04-15UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1649989/000000000020003262/0000000000-20-003262-index.htm
2020-03-05SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1649989/000091957420002136/0000919574-20-002136-index.htm
2020-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000094787120000157/0000947871-20-000157-index.htm
2020-02-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000094787120000158/0000947871-20-000158-index.htm
2020-02-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000094787120000159/0000947871-20-000159-index.htm
2020-03-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000094787120000253/0000947871-20-000253-index.htm
2020-03-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000094787120000256/0000947871-20-000256-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465919070676/0001104659-19-070676-index.htm
2019-12-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1649989/000110465919074095/0001104659-19-074095-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465919074372/0001104659-19-074372-index.htm
2019-12-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465919075334/0001104659-19-075334-index.htm
2019-12-23424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1649989/000110465919075336/0001104659-19-075336-index.htm
2019-12-30SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000110465919076834/0001104659-19-076834-index.htm
2020-01-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920006319/0001104659-20-006319-index.htm
2020-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920009271/0001104659-20-009271-index.htm
2020-01-31DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1649989/000110465920009273/0001104659-20-009273-index.htm
2020-01-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000110465920009335/0001104659-20-009335-index.htm
2020-02-03PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1649989/000110465920009855/0001104659-20-009855-index.htm
2020-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920021780/0001104659-20-021780-index.htm
2020-02-14DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1649989/000110465920021988/0001104659-20-021988-index.htm
2020-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1649989/000110465920022058/0001104659-20-022058-index.htm
2020-02-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1649989/000110465920024314/0001104659-20-024314-index.htm
2020-02-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920024322/0001104659-20-024322-index.htm
2020-03-10DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1649989/000110465920030973/0001104659-20-030973-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920037838/0001104659-20-037838-index.htm
2020-04-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920042542/0001104659-20-042542-index.htm
2020-04-08S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1649989/000110465920044699/0001104659-20-044699-index.htm
2020-04-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000110465920047348/0001104659-20-047348-index.htm
2020-04-17424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1649989/000110465920048268/0001104659-20-048268-index.htm
2020-04-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920048274/0001104659-20-048274-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920049230/0001104659-20-049230-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920059556/0001104659-20-059556-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920062746/0001104659-20-062746-index.htm
2020-05-15S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1649989/000110465920062768/0001104659-20-062768-index.htm
2020-05-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920067132/0001104659-20-067132-index.htm
2020-05-29424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1649989/000110465920067347/0001104659-20-067347-index.htm
2020-06-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000110465920072922/0001104659-20-072922-index.htm
2020-06-12SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000110465920072924/0001104659-20-072924-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920074008/0001104659-20-074008-index.htm
2020-06-23424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1649989/000110465920076066/0001104659-20-076066-index.htm
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920076104/0001104659-20-076104-index.htm
2020-06-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920076106/0001104659-20-076106-index.htm
2020-07-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000110465920087467/0001104659-20-087467-index.htm
2020-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920095054/0001104659-20-095054-index.htm
2020-08-18DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1649989/000110465920096526/0001104659-20-096526-index.htm
2020-08-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920098520/0001104659-20-098520-index.htm
2020-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920106584/0001104659-20-106584-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920110496/0001104659-20-110496-index.htm
2020-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920113974/0001104659-20-113974-index.htm
2020-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000110465920122585/0001104659-20-122585-index.htm
2019-01-03SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000114420419000410/0001144204-19-000410-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419002274/0001144204-19-002274-index.htm
2019-02-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000114420419005052/0001144204-19-005052-index.htm
2019-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419008128/0001144204-19-008128-index.htm
2019-02-14POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1649989/000114420419008163/0001144204-19-008163-index.htm
2019-02-14S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1649989/000114420419008186/0001144204-19-008186-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419008194/0001144204-19-008194-index.htm
2019-02-21S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1649989/000114420419009191/0001144204-19-009191-index.htm
2019-03-01424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419011666/0001144204-19-011666-index.htm
2019-03-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419012214/0001144204-19-012214-index.htm
2019-03-07S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1649989/000114420419012648/0001144204-19-012648-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419014626/0001144204-19-014626-index.htm
2019-03-19S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1649989/000114420419014735/0001144204-19-014735-index.htm
2019-04-02S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1649989/000114420419017715/0001144204-19-017715-index.htm
2019-04-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000114420419017725/0001144204-19-017725-index.htm
2019-04-02CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000114420419017731/0001144204-19-017731-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419018287/0001144204-19-018287-index.htm
2019-04-05CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000114420419018389/0001144204-19-018389-index.htm
2019-04-09S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1649989/000114420419018747/0001144204-19-018747-index.htm
2019-04-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000114420419018750/0001144204-19-018750-index.htm
2019-04-09CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000114420419018751/0001144204-19-018751-index.htm
2019-04-10S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419018964/0001144204-19-018964-index.htm
2019-04-10POS EXPost-effective amendment adding exhibits to registration statement [Rule 462(d)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419018965/0001144204-19-018965-index.htm
2019-04-10424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419019089/0001144204-19-019089-index.htm
2019-04-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000114420419019932/0001144204-19-019932-index.htm
2019-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419021631/0001144204-19-021631-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419026623/0001144204-19-026623-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419026624/0001144204-19-026624-index.htm
2019-06-03S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1649989/000114420419029513/0001144204-19-029513-index.htm
2019-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419030477/0001144204-19-030477-index.htm
2019-06-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419031045/0001144204-19-031045-index.htm
2019-06-14424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419031046/0001144204-19-031046-index.htm
2019-06-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1649989/000114420419031525/0001144204-19-031525-index.htm
2019-06-21CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000114420419031927/0001144204-19-031927-index.htm
2019-06-24CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1649989/000114420419032076/0001144204-19-032076-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419033098/0001144204-19-033098-index.htm
2019-07-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419033423/0001144204-19-033423-index.htm
2019-07-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419035750/0001144204-19-035750-index.htm
2019-08-01DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1649989/000114420419037252/0001144204-19-037252-index.htm
2019-08-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419040101/0001144204-19-040101-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1649989/000114420419040129/0001144204-19-040129-index.htm
2019-09-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1649989/000114420419044576/0001144204-19-044576-index.htm
2019-09-30S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1649989/000114420419046548/0001144204-19-046548-index.htm
2018-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919118064382/0001209191-18-064382-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119000912/0001209191-19-000912-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119001265/0001209191-19-001265-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119002918/0001209191-19-002918-index.htm
2019-01-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119003446/0001209191-19-003446-index.htm
2019-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119003962/0001209191-19-003962-index.htm
2019-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119004233/0001209191-19-004233-index.htm
2019-01-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119004571/0001209191-19-004571-index.htm
2019-01-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119005247/0001209191-19-005247-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119005917/0001209191-19-005917-index.htm
2019-02-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119006603/0001209191-19-006603-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119007382/0001209191-19-007382-index.htm
2019-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119007844/0001209191-19-007844-index.htm
2019-02-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119008782/0001209191-19-008782-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119011377/0001209191-19-011377-index.htm
2019-02-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119011378/0001209191-19-011378-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119022631/0001209191-19-022631-index.htm
2019-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119024794/0001209191-19-024794-index.htm
2019-06-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119038105/0001209191-19-038105-index.htm
2019-07-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119039777/0001209191-19-039777-index.htm
2019-09-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119049497/0001209191-19-049497-index.htm
2019-09-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119050468/0001209191-19-050468-index.htm
2019-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119051134/0001209191-19-051134-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119052708/0001209191-19-052708-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119052709/0001209191-19-052709-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119052710/0001209191-19-052710-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119052711/0001209191-19-052711-index.htm
2019-10-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119052712/0001209191-19-052712-index.htm
2019-10-154/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119053184/0001209191-19-053184-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119062163/0001209191-19-062163-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919119062314/0001209191-19-062314-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120002167/0001209191-20-002167-index.htm
2020-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120005415/0001209191-20-005415-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120020508/0001209191-20-020508-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120020509/0001209191-20-020509-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120020510/0001209191-20-020510-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120020511/0001209191-20-020511-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120020512/0001209191-20-020512-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120025300/0001209191-20-025300-index.htm
2020-04-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120025301/0001209191-20-025301-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120025302/0001209191-20-025302-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120025303/0001209191-20-025303-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120025304/0001209191-20-025304-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120025305/0001209191-20-025305-index.htm
2020-06-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120038574/0001209191-20-038574-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120038577/0001209191-20-038577-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120041199/0001209191-20-041199-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120041328/0001209191-20-041328-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120041363/0001209191-20-041363-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043215/0001209191-20-043215-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043217/0001209191-20-043217-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043218/0001209191-20-043218-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043221/0001209191-20-043221-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043223/0001209191-20-043223-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043224/0001209191-20-043224-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043226/0001209191-20-043226-index.htm
2020-07-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120043228/0001209191-20-043228-index.htm
2020-09-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120050564/0001209191-20-050564-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120051046/0001209191-20-051046-index.htm
2020-09-174/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120051048/0001209191-20-051048-index.htm
2020-09-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120051507/0001209191-20-051507-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053865/0001209191-20-053865-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053866/0001209191-20-053866-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053867/0001209191-20-053867-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053870/0001209191-20-053870-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053871/0001209191-20-053871-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053872/0001209191-20-053872-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053873/0001209191-20-053873-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000120919120053875/0001209191-20-053875-index.htm
2020-03-11DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000123191920000013/0001231919-20-000013-index.htm
2020-06-09DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1649989/000123191920000037/0001231919-20-000037-index.htm
2019-01-03SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1649989/000153561019000005/0001535610-19-000005-index.htm
2019-05-22SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1649989/000153561019000086/0001535610-19-000086-index.htm
2020-01-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1649989/000153561020000023/0001535610-20-000023-index.htm
2020-02-24SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1649989/000153561020000074/0001535610-20-000074-index.htm
2020-02-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1649989/000155837020000838/0001558370-20-000838-index.htm
2020-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1649989/000155837020006752/0001558370-20-006752-index.htm
2020-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1649989/000155837020010682/0001558370-20-010682-index.htm
2019-02-27EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1649989/999999999519000330/9999999995-19-000330-index.htm
2019-04-09EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1649989/999999999519000647/9999999995-19-000647-index.htm
2019-06-26EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1649989/999999999519001451/9999999995-19-001451-index.htm
2020-04-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1649989/999999999520000784/9999999995-20-000784-index.htm
2019-02-22SEC STAFF SEC Staff Action: ORDERhttps://www.sec.gov/Archives/edgar/data/1649989/999999999719000523/9999999997-19-000523-index.htm
2019-02-26CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1649989/999999999719000589/9999999997-19-000589-index.htm

Outlook Therapeutics, Inc (OTLK) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Outlook Therapeutics, Inc (OTLK). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 5719%
Institutional Ownership: 309%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-09-17Faisal Ghiath SukhtianDirectorBuy10,000.000.676,731.0010,000.00https://www.sec.gov/Archives/edgar/data/1649989/000120919120051046/0001209191-20-051046-index.htm
2020-09-22Yezan Munther HaddadinDirectorBuy10,000.000.727,245.0010,000.00https://www.sec.gov/Archives/edgar/data/1649989/000120919120051507/0001209191-20-051507-index.htm
2019-01-10KURT J HILZINGERDirectorBuy6,053.000.704,237.10104,682.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119003446/0001209191-19-003446-index.htm
2019-01-14KURT J HILZINGERDirectorBuy4,399.000.713,123.29109,081.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119003962/0001209191-19-003962-index.htm
2019-01-15KURT J HILZINGERDirectorBuy2,266.000.701,586.20111,347.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119003962/0001209191-19-003962-index.htm
2019-01-16KURT J HILZINGERDirectorBuy800.000.68544.00112,147.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119004571/0001209191-19-004571-index.htm
2019-01-17KURT J HILZINGERDirectorBuy2,300.000.691,587.00114,447.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119004571/0001209191-19-004571-index.htm
2019-04-12Pte Ltd. BioLexisDirectorBuy3,636,364.002.7510,000,001.0011,857,676.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119024794/0001209191-19-024794-index.htm
2020-09-14RANDY H THURMANDirectorBuy10,000.000.626,200.0011,875.00https://www.sec.gov/Archives/edgar/data/1649989/000120919120050564/0001209191-20-050564-index.htm
2020-03-19Jeff EvansonChief Commercial OfficerBuy1,207,457.001,207,457.00https://www.sec.gov/Archives/edgar/data/1649989/000120919120025305/0001209191-20-025305-index.htm
2020-03-19Terry DagnonChief Operating OfficerBuy1,207,457.001,207,457.00https://www.sec.gov/Archives/edgar/data/1649989/000120919120025304/0001209191-20-025304-index.htm
2019-01-22KURT J HILZINGERDirectorBuy10,749.000.687,309.32125,196.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119005247/0001209191-19-005247-index.htm
2019-01-23KURT J HILZINGERDirectorBuy2,266.000.671,518.22127,462.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119005247/0001209191-19-005247-index.htm
2019-01-25KURT J HILZINGERDirectorBuy10,828.000.697,471.32138,290.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119005917/0001209191-19-005917-index.htm
2019-06-17Pte Ltd. BioLexisDirectorBuy2,181,818.0014,039,494.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119038105/0001209191-19-038105-index.htm
2019-01-28KURT J HILZINGERDirectorBuy15,884.000.7111,277.64154,174.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119005917/0001209191-19-005917-index.htm
2019-01-29KURT J HILZINGERDirectorBuy5,400.000.733,942.00159,574.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119005917/0001209191-19-005917-index.htm
2019-01-30KURT J HILZINGERDirectorBuy4,890.000.723,520.80164,464.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119006603/0001209191-19-006603-index.htm
2020-07-15Syntone Ventures LLC10% Share HolderBuy823,045.001.22999,999.6816,823,045.00https://www.sec.gov/Archives/edgar/data/1649989/000110465920087467/0001104659-20-087467-index.htm
2019-12-23Pte Ltd. BioLexisDirectorBuy2,909,091.000.23674,909.1116,948,585.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119062163/0001209191-19-062163-index.htm
2019-01-31KURT J HILZINGERDirectorBuy6,300.000.754,725.00170,764.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119006603/0001209191-19-006603-index.htm
2019-02-01KURT J HILZINGERDirectorBuy8,200.000.776,314.00178,964.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119006603/0001209191-19-006603-index.htm
2019-02-04KURT J HILZINGERDirectorBuy5,983.000.804,786.40184,947.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119007844/0001209191-19-007844-index.htm
2020-01-29Pte Ltd. BioLexisDirectorBuy4,657,852.000.231,080,621.6621,606,437.00https://www.sec.gov/Archives/edgar/data/1649989/000120919120005415/0001209191-20-005415-index.htm
2020-02-26Ghiath M. SukhtianDirectorBuy2,460,630.001.022,500,000.082,460,630.00https://www.sec.gov/Archives/edgar/data/1649989/000094787120000157/0000947871-20-000157-index.htm
2020-03-23Pte Ltd. BioLexisDirectorBuy29,358,621.0050,965,058.00https://www.sec.gov/Archives/edgar/data/1649989/000094787120000253/0000947871-20-000253-index.htm
2019-01-02Pte Ltd. BioLexisDirectorBuy4,288,624.000.933,999,999.6061,481,879.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119000912/0001209191-19-000912-index.htm
2019-02-01Pte Ltd. BioLexisDirectorBuy4,288,624.000.933,999,999.6065,770,503.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119007382/0001209191-19-007382-index.htm
2019-01-15Pankaj MohanDirectorBuy8,000.000.685,440.007,064,553.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119004233/0001209191-19-004233-index.htm
2018-12-31KURT J HILZINGERDirectorBuy11,349.000.596,695.9172,216.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119001265/0001209191-19-001265-index.htm
2019-01-02KURT J HILZINGERDirectorBuy1,640.000.59967.6073,856.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119001265/0001209191-19-001265-index.htm
2019-01-03KURT J HILZINGERDirectorBuy4,200.000.592,478.0078,056.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119001265/0001209191-19-001265-index.htm
2019-09-18LAWRENCE A KENYONCEO, Pres, CFO, Treas & SecySell1,350.001.702,295.0080,863.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119050468/0001209191-19-050468-index.htm
2019-02-07LAWRENCE A KENYONCEO, Pres, CFO, Treas & SecyBuy25,000.000.9022,380.0082,213.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119008782/0001209191-19-008782-index.htm
2019-01-04KURT J HILZINGERDirectorBuy6,205.000.593,660.9584,261.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119002918/0001209191-19-002918-index.htm
2019-01-07KURT J HILZINGERDirectorBuy5,166.000.633,254.5889,427.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119002918/0001209191-19-002918-index.htm
2019-01-08KURT J HILZINGERDirectorBuy6,410.000.654,166.5095,837.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119002918/0001209191-19-002918-index.htm
2019-01-09KURT J HILZINGERDirectorBuy2,792.000.732,038.1698,629.00https://www.sec.gov/Archives/edgar/data/1649989/000120919119003446/0001209191-19-003446-index.htm